We are fundraising to run a trial of immunotherapy for women whose first round of chemotherapy has not completely eradicated their disease.

What is the trial?

This trial will offer women immunotherapy treatment instead of multi-agent chemotherapy to try and cure their disease. The trial will combine Pembrolizumab, an immunotherapy drug, with one of the single chemotherapy drugs normally used to treat this cancer. It is already used to treat other cancers such as melanoma and kidney cancer.

Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. It helps your immune system to recognise and fight cancer cells. It can educate the immune system to recognize and attack specific cancer cells and boost immune cells to help them eliminate cancer.

It is much less toxic than giving multi-drug chemotherapy. We expect this trial will save more women from the toxic effects of multi-drug chemotherapy which can include hair loss, infections and longer term problems such as an earlier menopause. 

We need your help to fund this trial to enable women to be cured of GTD without having to endure the toxic effects of multi-drug chemotherapy.